Skip to main content
[Preprint]. 2021 Jan 7:2021.01.07.425740. [Version 1] doi: 10.1101/2021.01.07.425740

Figure 1. 50% plaque reduction neutralization titers of 20 sera from BNT162b2 vaccine recipients against N501 and Y501 SARS-CoV-2.

Figure 1.

Seven sera (indicated by triangles) were drawn 2 weeks after the second dose of vaccine; 13 sera (indicated by circles) were drawn 4 weeks after the second dose.